Inventor · disambiguated record
Liang Chen
Also filed as: CHEN LIANG · CHEN LIANG-CHIEH
15 granted patents·18 pending applications·14 citations·filing 2001–2023
87Inventor score
Files withSUNSHINE LAKE PHARMA CO LTD12BETTA PHARMACEUTICALS CO LTD4FMC CORP4LILLY CO ELI2SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD2
Top patents by PatentIndex Score
33 records- 0188US11542241B2Efficient new process for synthesis of 2-amino-5-chloro-N,3-dimethylbenzamideFMC CORP·Filed 2022·Granted Jan 3, 2023·2 cites·11 claims
- 0283US9255111B2Parasiticidal dihydroisoxazole compoundsLILLY CO ELI·Filed 2014·Granted Feb 9, 2016·5 cites·20 claims
- 0374US8889710B2Parasiticidal dihydroisoxazole compoundsLILLY CO ELI·Filed 2013·Granted Nov 18, 2014·2 cites·36 claims
- 0473US8648081B2Parasiticidal dihydroisoxazole compoundsAN ZENGYUN·Filed 2012·Granted Feb 11, 2014·4 cites·38 claims
- 0568US12304893B2Process for synthesis of 2-amino-5-chloro-N-,3-dimethylbenzamideFMC CORP·Filed 2022·Granted May 20, 2025·0 cites·17 claims
- 0665US9902712B2Nitrogenous heterocyclic derivatives and their application in drugsSUNSHINE LAKE PHARMA CO LTD·Filed 2014·Granted Feb 27, 2018·1 cites·16 claims
- 0760US2025115553A1An efficient new process for synthesis of 2-amino-5-chloro-n-,3-dimethylbenzamideFMC CORP·Filed 2023·Application pending·0 cites
- 0860US2024352053A1Salt and crystal form of egfr inhibitor, and composition and use thereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0957US2025154149A1Pharmaceutical composition and method for preparing active ingredient compound thereofBETTA PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1056US2025262191A1New crystal form of nitrogen-containing tricyclic compound and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1155US10851068B2Method for preparing pyrimidone compoundSUNSHINE LAKE PHARMA CO LTD·Filed 2018·Granted Dec 1, 2020·0 cites·22 claims
- 1255US2024246994A1Polymorph Of Imidazolidinone Compound, Preparation Method Therefor And Use ThereofBETTA PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1355US2024383864A1Method for preparing azoxystrobin and intermediate thereofANHUI GUANGXIN AGROCHEMICAL CO·Filed 2023·Application pending·0 cites
- 1454US2008112967A1Process for Refining Ganoderma Spore PolysacchorideNANJING ZHONGKE GROUP CORP LTD·Filed 2006·Application pending·0 cites
- 1553US2025268871A1New crystal form of nitrogen-containing tricyclic compound and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1651US2024376051A1Crystalline form of pyrrole amide compound, preparation method therefor and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1750US2022267296A1Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acidFMC CORP·Filed 2020·Application pending·0 cites
- 1850US2024174681A1Salt and crystalline forms of fgfr4 inhibitor and uses thereofBETTA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1949US12262712B2Oxime ether compound and application thereofSHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD·Filed 2020·Granted Apr 1, 2025·0 cites·9 claims
- 2049US2023002325A1Crystal form of quinolinone compound and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2148US2023002400A1Amorphous form of nitrogen-containing tricyclic compound and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2248US2024409549A1New crystal form and use of nitrogenous tricyclic compoundSUNSHINE LAKE PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2347US12358895B2Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereofACEA THERAPEUTICS INC·Filed 2018·Granted Jul 15, 2025·0 cites·18 claims
- 2447US10544092B2Malononitrile oxime ether compound and use thereofSHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD·Filed 2016·Granted Jan 28, 2020·0 cites·13 claims
- 2546US12492211B2Crystalline form of nitrogen-containing tricyclic compound and use thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2020·Granted Dec 9, 2025·0 cites·11 claims
- 2645US2004116016A1Method for the addition of anti-microbial compounds to fiberglas insulation productsFiled 2002·Application pending·0 cites
- 2743US11213529B2Salt of substituted urea derivative and use thereof in medicineSUNSHINE LAKE PHARMA CO LTD·Filed 2018·Granted Jan 4, 2022·0 cites·18 claims
- 2843US2022323454A1Phenothiazines and their derivatives for use as a medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2940US10647682B2Salts of 2,6-dimethylpyrimidone derivatives and uses thereofSUNSHINE LAKE PHARMA CO LTD·Filed 2017·Granted May 12, 2020·0 cites·14 claims
- 3039US10532991B2Method for preparing hispidulin and its derivativesUNIV TAIPEI MEDICAL·Filed 2018·Granted Jan 14, 2020·0 cites·15 claims
- 3139US2004053996A1Use of oxabicyclo[2.2.1]heptane derivatives as pesticidal agentsFiled 2002·Application pending·0 cites
- 3237US2004068004A1Use of oxabicyclo[2.2.1]heptadiene derivatives as pesticidal agentsFiled 2001·Application pending·0 cites
- 3335US10098889B2Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticalsSUNSHINE LAKE PHARMA CO LTD·Filed 2016·Granted Oct 16, 2018·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Liang Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →